24,25-epoxycholesterol has been researched along with phloroglucinol in 1 studies
*Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent. [MeSH]
*Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent. [MeSH]
Studies (24,25-epoxycholesterol) | Trials (24,25-epoxycholesterol) | Recent Studies (post-2010) (24,25-epoxycholesterol) | Studies (phloroglucinol) | Trials (phloroglucinol) | Recent Studies (post-2010) (phloroglucinol) |
---|---|---|---|---|---|
65 | 0 | 18 | 1,775 | 40 | 876 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castell, JV; Gómez-Lechón, MJ; Jover, R; Moya, M | 1 |
1 other study(ies) available for 24,25-epoxycholesterol and phloroglucinol
Article | Year |
---|---|
Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.
Topics: Androstenols; Bridged Bicyclo Compounds; Calcifediol; Cells, Cultured; Cholesterol; Farnesol; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Indoles; Ligands; Phloroglucinol; PPAR gamma; Pregnenediones; Receptors, Cytoplasmic and Nuclear; Selective Estrogen Receptor Modulators; Tamoxifen; Terpenes; Vitamin A | 2010 |